Advertisement
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination

September 19, 2017

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination

Karen Canfell and colleagues report results of the Compass trial; in a large Australian cohort, HPV screening is superior to pap smears for pre-cancerous lesion identification. Read the Author Summary

Image credit: Hey Paul Studios, Flickr

PLOS Medicine Special Issue: Cardiovascular disease and multimorbidity

Call for Papers: Research submissions are now being invited, with a deadline of October 6, 2017

Click Here

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again